aTyr Pharma | LIFE - Cost Of Sales

Stock Price
0.90
Daily Change
0.09 10.89%
Monthly
20.43%
Yearly
-76.95%
Q1 Forecast
0.86

aTyr Pharma reported $22.13M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Ardelyx USD 3.98M 10.84M Sep/2025
aTyr Pharma USD 22.13M 6.75M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Cipla INR 29.1B 1.16B Dec/2025
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 1.65M 10K Sep/2025
CSL USD 1.79B 2.15B Jun/2025
Galapagos EUR 84.73M 80.02M Sep/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Grifols EUR 1.32B 22.75M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
United Therapeutics USD 100.9M 74.3M Sep/2025